Other formats:
BibTeX
LaTeX
RIS
@proceedings{2312159,
author = {Straka, Matej and Andrašina, Tomáš and Hustý, Jakub and Matkulčík, Peter and Kazda, Tomáš and Rohan, Tomáš},
booktitle = {CIRSE 2023},
keywords = {Transarterial chemoembolization; hepatocellular carcinoma; comorbidities; remission},
language = {eng},
title = {Transarterial chemoembolization of hepatocellular carcinoma in patients with the most common comorbidities or previous oncologic malignancy in remission.},
year = {2023}
}
TY - CONF
ID - 2312159
AU - Straka, Matej - Andrašina, Tomáš - Hustý, Jakub - Matkulčík, Peter - Kazda, Tomáš - Rohan, Tomáš
PY - 2023
TI - Transarterial chemoembolization of hepatocellular carcinoma in patients with the most common comorbidities or previous oncologic malignancy in remission.
KW - Transarterial chemoembolization
KW - hepatocellular carcinoma
KW - comorbidities
KW - remission
N2 - Purpose: To analyze whether previously diagnosed common comorbidity (diabetes mellitus, myocardial infarction, ischemic stroke, chronic obstructive pulmonary disease (COPD) or prior malignancy in complete remission (CR) are independent risk factors afecting survival of patients with hepatocellular carcinoma (HCC) treated with transarterial chemoembolisation (TACE). Conclusion: Patiens with HCC treated with TACE and a history of mentioned comorbidities or other malignant tumor in complete remission have non-inferior survival compared to patients without comorbidities.
ER -
STRAKA, Matej, Tomáš ANDRAŠINA, Jakub HUSTÝ, Peter MATKULČÍK, Tomáš KAZDA and Tomáš ROHAN. Transarterial chemoembolization of hepatocellular carcinoma in patients with the most common comorbidities or previous oncologic malignancy in remission. In \textit{CIRSE 2023}. 2023.
|
